Fox 2 Detroit Interview: Why the New Cholesterol Guidelines Matter
If you think cholesterol is just about “good” and “bad” numbers, the new national guidelines say it is time for a more complete conversation.
In my recent Fox 2 Detroit interview, I discussed the 2026 cholesterol guideline update and what it means for people who want to take a proactive approach to heart health. The shift is meaningful: the new recommendations push screening and treatment discussions earlier, use a newer risk calculator, and place more emphasis on advanced markers that can uncover risk traditional panels may miss.
Earlier screening, earlier action
One of the biggest updates is timing. The new guidance supports cholesterol screening and treatment discussions earlier in adulthood, with risk assessment beginning as young as age 30 in appropriate patients. It also recommends using the newer PREVENT-ASCVD equations for adults ages 30 to 79 without known cardiovascular disease to estimate both 10-year and 30-year risk.
That matters because plaque builds over time. Waiting until someone is older — or until a standard lipid panel looks dramatically abnormal — can miss years of silent risk exposure. The new framework is more aligned with the idea that preventing disease earlier is more powerful than reacting to it later.
Why LDL still matters — but is not the whole story
LDL cholesterol remains central because elevated LDL is a major driver of atherosclerotic cardiovascular disease. But the updated guideline also brings back clearer LDL-C goals tied to risk. In broad terms, lower-risk primary prevention patients may aim for LDL-C below 100 mg/dL, higher-risk groups may warrant targets below 70 mg/dL, and very-high-risk secondary prevention patients may warrant goals below 55 mg/dL.
At the same time, the guideline recognizes what many preventive cardiology experts have been saying for years: LDL-C alone does not always tell the full story. ApoB can be especially useful in people with diabetes, high triglycerides, cardiometabolic dysfunction, or known cardiovascular disease because it better reflects the number of atherogenic particles. Lp(a), a largely genetic marker, should now be measured at least once in adulthood because elevated levels can meaningfully raise lifetime cardiovascular risk.
Where calcium scoring fits in
Another important point is selective use of coronary artery calcium, or CAC, scoring. The guideline supports CAC testing in certain men age 40 and older and women age 45 and older when treatment decisions remain uncertain after routine risk assessment. In the right patient, CAC can help clarify whether risk is theoretical or already showing up as calcified plaque.
That said, CAC is a tool — not a free pass. Preventive cardiology experts have also emphasized that a zero calcium score does not mean zero risk, especially when apoB is elevated or other risk factors are present.
What this means for patients
The real message of the new cholesterol guidelines is simple: heart disease prevention is becoming more personalized.
For some people, a standard lipid panel and lifestyle counseling may be enough. For others, the more useful conversation may include apoB, Lp(a), inflammation markers, insulin resistance, coronary calcium scoring, or even more advanced imaging depending on the clinical picture. The goal is not to order more tests for the sake of it. The goal is to identify risk earlier and act with precision.
At Synergy, that is how we approach cardiovascular prevention. We do not want to guess based on one number if the fuller picture suggests otherwise. We want to understand your actual risk, explain it clearly, and build a plan that matches it.
Because when it comes to cholesterol, better screening is only useful if it leads to better decisions.